Back
Adobe, Inc. Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison
Sell
50
ADBE
Adobe, Inc.
Last Price:
$346.30
Seasonality Move:
8.82%
Buy
57
RYTM
Rhythm Pharmaceuticals, Inc.
Last Price:
$104.56
Seasonality Move:
-6.7%
Sell
50
Adobe, Inc. (ADBE)
is a Sell
Is Adobe, Inc. a Buy, Sell or Hold?
-
The current Adobe, Inc. [ADBE] share price is $346.26. The Score for ADBE is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
ADBE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Rhythm Pharmaceuticals, Inc. (RYTM)
is a Buy
Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $104.60. The Score for RYTM is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ADBE Stock Price Chart
What is Adobe, Inc.'s stock price today?
-
The Adobe, Inc. share price today is $346.26Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ADBE is experiencing buying pressure, which is a positive indicator for future bullish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals, Inc.'s stock price today?
-
The Rhythm Pharmaceuticals, Inc. share price today is $104.60The current trend is moderately bullish and RYTM is experiencing slight selling pressure.
ADBE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.13 | Sell |
| Relative Strength Index (14 RSI): | 63.37 | Buy |
| Chaikin Money Flow: | 5762089 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (319.79 - 335.77) | Buy |
| Bollinger Bands (100): | (331.71 - 361.17) | Sell |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.35 | Buy |
| Relative Strength Index (14 RSI): | 50.78 | Buy |
| Chaikin Money Flow: | -195325 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (98.6 - 107.92) | Buy |
| Bollinger Bands (100): | (92.83 - 106.97) | Buy |
ADBE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 325.58 | Buy |
| 20-day SMA: | 325.92 | Buy |
| 50-day SMA: | 337.34 | Buy |
| 200-day SMA: | 369.61 | Sell |
| 8-day EMA: | 329.04 | Buy |
| 20-day EMA: | 328.44 | Buy |
| 50-day EMA: | 336 | Buy |
| 200-day EMA: | 374.4 | Sell |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 105.83 | Sell |
| 20-day SMA: | 102.55 | Buy |
| 50-day SMA: | 104.26 | Buy |
| 200-day SMA: | 80.37 | Buy |
| 8-day EMA: | 104.76 | Sell |
| 20-day EMA: | 104.28 | Buy |
| 50-day EMA: | 102.89 | Buy |
| 200-day EMA: | 85.54 | Buy |
Adobe, Inc. Earnings Growth & ADBE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.53 per share, and an increase next year of $2.51 per share.
Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.66 per share.
Adobe, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||